Literature DB >> 17030571

Role of the wbt locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity.

Catherine Raynaud1, Karin L Meibom, Marie-Annick Lety, Iharilalao Dubail, Thomas Candela, Eric Frapy, Alain Charbit.   

Abstract

Francisella tularensis is a highly infectious bacterial pathogen, responsible for the zoonotic disease tularemia. We screened a bank of transposon insertion mutants of F. tularensis subsp. holarctica LVS for colony morphology alterations and selected a mutant with a transposon insertion in wbtA, the first gene of the predicted lipopolysaccharide O-antigen gene cluster. Inactivation of wbtA led to the complete loss of O antigen, conferred serum sensitivity, impaired intracellular replication, and severely attenuated virulence in the mouse model. Notably, this mutant afforded protection against a challenge against virulent LVS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030571      PMCID: PMC1828372          DOI: 10.1128/IAI.01429-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  [A graphic probit method for the calculation of LD50 and relative toxicity].

Authors:  Z ROTH
Journal:  Cesk Fysiol       Date:  1961-10

2.  Structural analysis of Francisella tularensis lipopolysaccharide.

Authors:  Evgeny Vinogradov; Malcolm B Perry; J Wayne Conlan
Journal:  Eur J Biochem       Date:  2002-12

3.  Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis.

Authors:  S C Cowley; C J Gray; F E Nano
Journal:  FEMS Microbiol Lett       Date:  2000-01-01       Impact factor: 2.742

4.  Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen.

Authors:  J Wayne Conlan; Evguenii Vinogradov; Mario A Monteiro; Malcolm B Perry
Journal:  Microb Pathog       Date:  2003-01       Impact factor: 3.738

5.  A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes.

Authors:  G Sandström; S Löfgren; A Tärnvik
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.

Authors:  J Wayne Conlan; Hua Shen; Ann Webb; Malcolm B Perry
Journal:  Vaccine       Date:  2002-10-04       Impact factor: 3.641

7.  Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis.

Authors:  Joann L Prior; Richard G Prior; Paul G Hitchen; Helen Diaper; Kate F Griffin; Howard R Morris; Anne Dell; Richard W Titball
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

8.  Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.

Authors:  Tara L Kieffer; Siobhan Cowley; Francis E Nano; Karen L Elkins
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

9.  A Francisella tularensis pathogenicity island required for intramacrophage growth.

Authors:  Francis E Nano; Na Zhang; Siobhán C Cowley; Karl E Klose; Karen K M Cheung; Michael J Roberts; Jagjit S Ludu; Gregg W Letendre; Anda I Meierovics; Gwen Stephens; Karen L Elkins
Journal:  J Bacteriol       Date:  2004-10       Impact factor: 3.490

10.  Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112).

Authors:  Evgeny Vinogradov; Wayne J Conlan; John S Gunn; Malcolm B Perry
Journal:  Carbohydr Res       Date:  2004-02-25       Impact factor: 2.104

View more
  60 in total

1.  Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.

Authors:  Stephen R Lindemann; Kaitian Peng; Matthew E Long; Jason R Hunt; Michael A Apicella; Denise M Monack; Lee-Ann H Allen; Bradley D Jones
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.

Authors:  Qingmei Jia; Bai-Yu Lee; Richard Bowen; Barbara Jane Dillon; Susan M Som; Marcus A Horwitz
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

4.  Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis.

Authors:  Kaitian Peng; Petr Broz; Jonathan Jones; Lydia-Marie Joubert; Denise Monack
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

5.  The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance.

Authors:  Elizabeth Di Russo Case; Audrey Chong; Tara D Wehrly; Bryan Hansen; Robert Child; Seungmin Hwang; Herbert W Virgin; Jean Celli
Journal:  Cell Microbiol       Date:  2013-12-16       Impact factor: 3.715

Review 6.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

7.  O antigen protects Bordetella parapertussis from complement.

Authors:  Elizabeth M Goebel; Daniel N Wolfe; Kelly Elder; Scott Stibitz; Eric T Harvill
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

8.  Identification of trkH, encoding a potassium uptake protein required for Francisella tularensis systemic dissemination in mice.

Authors:  Khaled Alkhuder; Karin L Meibom; Iharilalao Dubail; Marion Dupuis; Alain Charbit
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

9.  Azithromycin effectiveness against intracellular infections of Francisella.

Authors:  Saira Ahmad; Lyman Hunter; Aiping Qin; Barbara J Mann; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

Review 10.  Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Authors:  Roger D Pechous; Travis R McCarthy; Thomas C Zahrt
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.